|

Anti-LILRA6 CAR-T cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Second Affiliated Hospital, School of Medicine, Zhejiang University1

Indications

  • Refractory Acute Myeloid Leukemia1
  • Recurrent Acute Myeloid Leukemia1
  • Cancer1

Other1 trial

Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.